Rosuvastatin Calcium Tablet, Coated
Product Images NDC 13668-181

20 FDA label images from Torrent Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 13668-181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Rosuvastatinstructure)

Structure (Rosuvastatinstructure)
Chemical structure of Rosuvastatin Calcium, showing the molecular arrangement including the fluorophenyl group, sulfonamide group, and calcium ion complexation.*
FDA Label Image

Figure 1 (Rosuvastatinfigure1)

Figure 1 (Rosuvastatinfigure1)
A cumulative incidence curve comparing Rosuva (rosuvastatin calcium) to placebo over approximately 5 years, showing lower cumulative incidence percentages for Rosuva. The x-axis represents years, and the y-axis represents cumulative incidence percentage, with a risk table for RSV and placebo groups below the graph.*
FDA Label Image

Figure 2 (Rosuvastatinfigure2)

Figure 2 (Rosuvastatinfigure2)
A data table presenting the number of events and hazard ratios for various cardiovascular endpoints comparing Rosuvastatin Calcium 20 mg versus placebo 20 mg. It includes event counts, rates per 1000 patient years, hazard ratios with 95% confidence intervals, P values, and a graphical hazard ratio plot for endpoints such as primary MCE, cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization.*
FDA Label Image

Figure 3 (Rosuvastatinfigure3)

Figure 3 (Rosuvastatinfigure3)
A box plot chart comparing percent changes from baseline in LDL-C levels for four statin drugs—Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin—across various doses (10 mg, 20 mg, 40 mg, with additional 80 mg for Atorvastatin and Simvastatin). The vertical axis shows percent LDL-C change, ranging from 0 to -75%. The chart illustrates variability and median effects for each dose and drug.*
FDA Label Image

Table 10 (Table10)

Table 10 (Table10)
A data table presenting changes in lipid profile components (Total-C, LDL-C, Non-HDL-C, ApoB, TG, HDL-C) for different doses of Rosuvastatin tablets (5 mg, 10 mg, 20 mg, 40 mg) compared to placebo. The table includes sample sizes (N) and mean percentage changes for each lipid parameter.*
FDA Label Image

Table 11 (Table11)

Table 11 (Table11)
A data table comparing treatment daily doses of different statins, including Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin, across four dosage levels: 10 mg, 20 mg, 40 mg, and 80 mg. The table presents numerical values corresponding to each treatment and dosage combination.*
FDA Label Image

Table 12 (Table12)

Table 12 (Table12)
Data table comparing the least squares mean (LS Mean) percentage change with 95% confidence intervals for Rosuvastatin and Atorvastatin at different weeks and dosages, including week 6 (20 mg), week 12 (40 mg), and week 18 (80 mg) for Atorvastatin only. Sample sizes are 435 for Rosuvastatin and 187 for Atorvastatin.*
FDA Label Image

Table 13 (Table13)

Table 13 (Table13)
Data table presenting median percent changes in lipid parameters (LDL-C, HDL-C, Total-C, TG, ApoB) for different doses of Rosuvastatin Calcium (5 mg, 10 mg, 20 mg) compared to placebo, showing sample sizes (N) and noting statistical significance of differences from placebo where applicable.*
FDA Label Image

Table 15 (Table15)

Table 15 (Table15)
Data table presenting median baseline values (mg/dL) and median percent changes from baseline with 95% confidence intervals for Rosuvastatin Calcium tablets 10 mg and 20 mg. The table includes lipid profile components Total-C, Triglycerides, Non-HDL-C, VLDL-C + IDL-C, LDL-C, HDL-C, RLP-C, and Apo-E with corresponding percent changes.*
FDA Label Image

Table 16 (Table16)

Table 16 (Table16)
Data table showing the effect of varying doses of Rosuvastatin tablets (5 mg, 10 mg, 20 mg, 40 mg) compared to placebo on lipid parameters including triglycerides, non-HDL cholesterol, total cholesterol, LDL cholesterol, and HDL cholesterol. The table lists the number of subjects per group and changes in values with ranges in parentheses.*
FDA Label Image

Logo (Logo1)

FDA Label Image

Torrent Logo (Logo2)

FDA Label Image

5mg (Rosuvastatintablets30tabletsindrad5mg)

5mg (Rosuvastatintablets30tabletsindrad5mg)
Rosuvastatin Tablets, USP 5 mg film-coated oral tablets label showing 30 tablets per container. The label includes storage instructions, manufacturer Torrent Pharmaceuticals Limited (India), and distributor Torrent Pharma Inc. (New Jersey). It also states pharmacist dispensing instructions and provides a URL for patient information.*
FDA Label Image

5mg-dahej (Rosuvastatintablets30tabletsdahej5mg)

5mg-dahej (Rosuvastatintablets30tabletsdahej5mg)
Rosuvastatin Tablets, USP 5 mg film-coated oral tablets label for a bottle containing 30 tablets. The label shows storage instructions, dosage form, strength, and manufacturer information for Torrent Pharmaceuticals Limited and Torrent Pharma Inc.*
FDA Label Image

10mg (Rosuvastatin30tabletsindrad10mg)

10mg (Rosuvastatin30tabletsindrad10mg)
Label for Rosuvastatin Tablets USP 10 mg oral tablets, 30 count. The label states the product contains rosuvastatin calcium equivalent to 10 mg of rosuvastatin per film-coated tablet. It includes storage instructions and a caution to keep out of reach of children. Manufactured by Torrent Pharmaceuticals Limited, India, for Torrent Pharma Inc., New Jersey. The label also includes barcode and NDC 13668-180-30.*
FDA Label Image

10mg-dahej (Rosuvastatintablets30tabletsdahej10mg)

10mg-dahej (Rosuvastatintablets30tabletsdahej10mg)
Label for Rosuvastatin Tablets, USP 10 mg, containing 30 film-coated tablets. Manufactured by Torrent Pharmaceuticals Limited and labeled for oral use. Includes storage instructions and a note to dispense with a patient information sheet. The NDC is 13668-180-30.*
FDA Label Image

20mg (Rosuvastatintablets30tabletsindrad20mg)

20mg (Rosuvastatintablets30tabletsindrad20mg)
Rosuvastatin Tablets, USP 20 mg film-coated tablets label for a 30 count package by Torrent Pharma. The label includes storage instructions, dosage instruction references, and a patient information website. Marked as Rx only with the NDC code 13668-181-30.*
FDA Label Image

20mg-dahej (Rosuvastatintablets30tabletsdahej20mg)

20mg-dahej (Rosuvastatintablets30tabletsdahej20mg)
Label for Rosuvastatin Tablets USP 20 mg, coated oral tablets available in a 30 tablet package. The label shows the NDC code 13668-181-30 and states the product is for prescription use only (Rx only). It is labeled by Torrent Pharmaceuticals Limited and includes storage instructions and a patient information URL.*
FDA Label Image

40mg (Rosuvastatintablets30tabletsindrad40mg)

40mg (Rosuvastatintablets30tabletsindrad40mg)
Label for Rosuvastatin Tablets, USP 40 mg, in a package of 30 coated tablets for oral use. The label includes storage instructions, manufacturer information (Torrent Pharmaceuticals Limited), and an NDC number 13668-182-30. It states the product is prescription only (Rx only) and directs pharmacists to provide patient information with each dispensation.*
FDA Label Image

40mg-dahej (Rosuvastatintablets30tabletsdahej40mg)

40mg-dahej (Rosuvastatintablets30tabletsdahej40mg)
Label for Rosuvastatin Tablets, USP 40 mg, oral coated tablets, containing 30 tablets per package. The label includes storage instructions, caution to keep out of reach of children, and a reminder to dispensing pharmacists to provide a patient information sheet. Manufactured by Torrent Pharmaceuticals Limited, India, and labeled for Torrent Pharma INC, USA. Features NDC 13668-182-30 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.